Binge Eating Disorder (BED): Understanding and Seeking Help
Binge Eating Disorder (BED) is the most common eating disorder in the US, affecting 2–3% of adults. It involves recurrent binge eating without compensatory behaviors (purging, fasting, excessive exercise).
Diagnostic Criteria (DSM-5)
- Recurrent binge episodes (≥1×/week × 3 months)
- Binge = eating objectively large amount in discrete period (≤2 hrs) + sense of lack of control
- ≥3 of: eating rapidly, until uncomfortably full, when not hungry, alone (embarrassment), feeling disgusted/depressed/guilty afterward
- Marked distress
- No compensatory behaviors (distinguishes from bulimia)
Health Consequences
- Metabolic: Obesity (up to 2/3), insulin resistance, type 2 diabetes, dyslipidemia, NAFLD, metabolic syndrome
- Cardiovascular: Hypertension, atherosclerosis, heart failure
- Gastrointestinal: GERD, gallbladder disease, IBS
- Psychiatric: Depression, anxiety, substance use, suicidality
- Quality of life: Impaired social, occupational, sexual functioning
Evidence-Based Treatment
| Modality | Details |
|---|---|
| CBT-E (Enhanced CBT) | First-line psychotherapy; 20 sessions; targets dietary restraint, shape/weight concern, mood regulation |
| Interpersonal Therapy (IPT) | Alternative if CBT unavailable/ineffective; focuses on relational triggers |
| Dialectical Behavior Therapy (DBT) | For emotion dysregulation; skills: mindfulness, distress tolerance, emotion regulation |
| Lisdexamfetamine (Vyvanse) | Only FDA-approved medication for BED; 50–70 mg/day; reduces binge days; monitor BP/HR, misuse |
| Topiramate | Off-label; reduces binge frequency/weight; cognitive side effects |
| SSRIs | Modest benefit for comorbid depression/anxiety; not primary for BED |
